<Suppliers Price>

N-Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate

Names

[ CAS No. ]:
64987-85-5

[ Name ]:
N-Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate

[Synonym ]:
MFCD00009634
1-[(4-{[(2,5-Dioxopyrrolidin-1-yl)oxy]carbonyl}cyclohexyl)methyl]-1H-pyrrole-2,5-dione
1H-Pyrrole-2,5-dione, 1-((4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)cyclohexyl)methyl)-
N-Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
1-[(4-{[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl}cyclohexyl)methyl]-1H-pyrrole-2,5-dione
1H-pyrrole-2,5-dione, 1-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]-
N-Succinimidyl 4-(Maleimidomethyl)cyclohexane-1-carboxylate

Biological Activity

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
501.7±42.0 °C at 760 mmHg

[ Melting Point ]:
180-182 °C(lit.)

[ Molecular Formula ]:
C16H18N2O6

[ Molecular Weight ]:
334.324

[ Flash Point ]:
257.2±27.9 °C

[ Exact Mass ]:
334.116486

[ PSA ]:
101.06000

[ LogP ]:
-0.39

[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C

[ Index of Refraction ]:
1.598

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
chloroform: 50 mg/mL

MSDS

Safety Information

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2925190090

Synthetic Route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2925190090

[ Summary ]:
2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.

J. Immunol. Res. 2015 , 561814, (2015)

Antibody-drug conjugates (ADCs) have evolved as a new class of potent cancer therapeutics. We here report on the development of ADCs with specificity for the B-cell lineage specific (surface) antigen ...

Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.

Int. J. Pharm. 485 , 77-86, (2015)

Nanocrystallization is among the foremost drug delivery platform approaches for the commercial development of poorly soluble drugs. There exists an urge to enable a universal shift of the production o...

An NIR-triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates.

Nanoscale 7 , 12614-24, (2015)

Nanomaterials for effective drug delivery require zero pre-release and on-demand release of therapeutic drugs. In this work we demonstrate a novel drug delivery system composed of a mesoporous silica ...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.